Co-hosted by Regenerative Bio Limited and Liangzhu Laboratory, the Longevity 121 Artificial Intelligence and Aging Intervention Forum was successfully held in Hangzhou, China, on September 22, 2025.

Focusing on frontier advances in artificial intelligence, aging biology, regenerative medicine, and clinical translation, the forum brought together international scholars, clinical experts, and industry representatives to exchange insights on aging assessment, intervention strategies, translational medicine, and longevity innovation, advancing multidisciplinary research and the exploration of clinical applications.

The inaugural Artificial Intelligence and Aging Conference 2023 was initiated by Regenerative Bio. Focusing on the intersection of artificial intelligence and aging science, the conference brought together experts, scholars, and industry representatives from the fields of artificial intelligence, aging biology, clinical medicine, and the life and health industries.

Discussions centered on key topics including AI-driven aging assessment, longevity interventions, and translational medicine. During the conference, the Aging Clock Research Cohort was officially launched, advancing systematic exploration in biological age measurement, organ age assessment, and precision longevity research.